| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |